An Open‐Label, Single‐Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults

Amenamevir is an inhibitor of the helicase‐primase enzyme complex developed for the treatment of varicella zoster virus. This mass balance study investigated the absorption, metabolism, and excretion of a single dose (200 mg) of (14)C‐labeled amenamevir in healthy male volunteers. Blood, urine, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Kota, den Adel, Martin, Groenendaal‐van de Meent, Dorien, Ohtsu, Yoshiaki, Takada, Akitsugu, Katashima, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619336/
https://www.ncbi.nlm.nih.gov/pubmed/30412362
http://dx.doi.org/10.1002/cpdd.630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619336/
https://www.ncbi.nlm.nih.gov/pubmed/30412362
http://dx.doi.org/10.1002/cpdd.630

Ejemplares similares